Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations
Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces
Xaira Therapeutics Announces the Appointment of Jeff Jonker as President and Chief Operating Officer